From: Supporting the use of a coagulometric method for rivaroxaban control: a hypothesis-generating study to define the safety cut-offs
Correlation at trough (24 h)
R-C
aFXa Rivaroxaban
0,6881
P = 0.0001
Correlation at peak (2 h)
0,3908
P = 0.033